Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 18, 2015

Drug Name Review Type Class Manufacturer
Viekira Pak New Drug Initial Review Hepatitis C AbbVie
Zontivity New Drug Initial Review Platelet Aggregation Inhibitor Merck
Harvoni New Drug Initial Review Hepatitis C Gilead
Savaysa New Drug Initial Review Anticoagulant Daiichi Sankyo
Grastek New Drug Initial Review Allergen Extract Merck
Ragwitek New Drug Initial Review Allergen Extract Merck
Plegridy New Drug Initial Review Multiple Sclerosis Biogen Idec
Orbactiv New Drug Initial Review Antibiotic The Medicines Company